**Author details**

Leonardo de A. Calderon, Juliana P. Zuliani and Rodrigo G. Stábeli *Center of Applied Biomolecular Studies in Health (CEBio), Fiocruz Rondônia, Oswaldo Cruz Foundation - FIOCRUZ and Medicine Department, Federal University of Rondônia - UNIR, Porto Velho, RO, Brazil* 

Purification of Phospholipases A2 from American Snake Venoms 25

[1] Kordis D, Gubensek F (2000). Adaptive evolution of animal toxin multigene families.

[2] Menez A (1998). Functional architectures of animal toxins: a clue to drug design

[3] Kang T.S, Georgieva D, Genov N, Murakami M.T, Sinha M, Kumar R.P, Kaur P, Kumar S, Dey S, Sharma S, Vrielink A, Betzel C, Takeda S, Arni R. K, Singh T.P, Kini R.M (2011). Enzymatic toxins from snake venom: structural characterization and mechanism

[4] Calvete J.J, Juarez P, Sanz L (2007). Snake venomics. Strategy and applications. J. Mass

[6] Dennis E.A, Cao J, Hsu Y.H, Magrioti V, Kokotos G. (2011). Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and

[7] Gutierrez J.M, Ownby C.L, Odell G.V (1984). Isolation of a Myotoxin from *Bothrops asper* Venom - Partial Characterization and Action on Skeletal-Muscle. Toxicon 1: 115-128. [8] de Paula R.C, Castro H.C, Rodrigues C.R, Melo P.A, Fuly A.L (2009). Structural and pharmacological features of phospholipases A2 from snake venoms. Protein Pept. Lett.

[9] Soares A.M, Sestito W.P, Marcussi S, Stabeli R.G, Andriao-Escarso S. H, Cunha O.A, Vieira C.A, Giglio J.R (2004). Alkylation of myotoxic phospholipases A2 in *Bothrops moojeni* venom: a promising approach to an enhanced antivenom production. Int. J.

[10] Rodrigues V.M, Marcussi S, Cambraia R.S, de Araujo A.L, Malta-Neto N.R, Hamaguchi A, Ferro E.A, Homsi-Brandeburgo M.I, Giglio J.R, Soares A.M (2004). Bactericidal and neurotoxic activities of two myotoxic phospholipases A2 from *Bothrops neuwiedi* 

[11] Taghrid S, Istivan, T.S, Coloe, P. J (2006). Phospholipase A in Gram-negative bacteria

[12] Waite M (1996). Phospholipases. In Biochemistry of Lipids, Lipoproteins and Membranes, pp. 211–236. Edited by D. E. Vance & J. Vance. Amsterdam: Elsevier. [13] Dennis E.A (1994) Diversity of Group Types, Regulation, and Function of

[14] Dennis E.A (1997). The growing phospholipase A2 superfamily of signal transduction

[17] de Oliveira T.C, de Amorim H.L.N, Guimaraes J.A (2007). Interfacial activation of snake venom phospholipases A2 svPLA2 probed by molecular dynamics simulations. J. Mol.

[15] Arni R.K, Ward R.J (1996). Phospholipase A2 a structural review. Toxicon 8: 827-841. [16] Burke J.E, Dennis E.A (2009). Phospholipase A2 biochemistry. Cardiovasc. Drugs Ther.

[5] Mebs D (2001). Toxicity in animals. Trends in evolution. Toxicon 1: 87-96

therapeutic intervention. Chem. Rev. 10: 6130-6185.

**6. References** 

Gene 1: 43-52.

8: 899-907.

1: 49-59.

Toxicon 11: 1557-1572.

Spectrom. 11: 1405-1414.

of catalysis. FEBS J. 23: 4544-4576.

Biochem. Cell. Biol. 2: 258-270.

*pauloensis* snake venom. Toxicon 3: 305-314.

and its role in pathogenesis. Microbiology 152: 1263-1274.

Phospholipase A2. J. Biol. Chem. 269: 13057-13060.

enzymes. Trends Biochem. Sci. 22: 1-2.

Struct. Theochem. 1-3: 31-41.

Andreimar M. Soares *Center of Applied Biomolecular Studies in Health (CEBio), Fiocruz Rondônia, Oswaldo Cruz Foundation - FIOCRUZ, Porto Velho, RO, Brazil* 

Anderson M. Kayano, Antonio C. Neto, Andrea A. de Moura and Gizeli S. Gimenez *Experimental Biology, Federal University of Rondônia - UNIR, Porto Velho, RO, Brazil* 

Kayena D. Zaqueo and Rodrigo S. Silva *Biodiversity and Biotechnology, Bionorte Web, Porto Velho, RO, Brazil* 

*Experimental Biology, Federal University of Rondônia - UNIR, Porto Velho, RO, Brazil* 

Cleópatra A. S. Caldeira *Biological Sciences, Federal University of Rondônia - UNIR, Porto Velho, RO, Brazil* 
